| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/11/2008 | EP1930330A1 Pleuromutilin derivatives as antimicrobials |
| 06/11/2008 | EP1930319A1 Proline derivatives and use thereof as drugs |
| 06/11/2008 | EP1930026A1 A method for generating birnavirus from synthetic RNA transcripts |
| 06/11/2008 | EP1930021A2 Novel amide derivatives as growth hormone secretagogues |
| 06/11/2008 | EP1930015A1 Use of carrageenan for treating rhinovirus infections |
| 06/11/2008 | EP1930006A1 Method for production of quinolone-containing lyophilized preparation |
| 06/11/2008 | EP1930002A1 Use of hydroxybenzoic acid ester and analogues for the manufacture of a mendicament for the prevention and treatment of virus infection |
| 06/11/2008 | EP1928893A2 Triazole compounds and methods of making and using the same |
| 06/11/2008 | EP1928892A2 Glycomimetic inhibitors of the pa-il lectin, pa-iil lectin or both the lectins from pseudomonas |
| 06/11/2008 | EP1928890A2 Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections |
| 06/11/2008 | EP1928878A1 Methods for the preparation of hcv polymerase inhibitors |
| 06/11/2008 | EP1928877A1 Purine derivatives for the treatment of viral or allergic diseases and cancers |
| 06/11/2008 | EP1928876A1 Purine derivatives having immuno-modulating properties |
| 06/11/2008 | EP1928553A2 N-(1-pyrene)maleimide, iaans and 5-(bromomethyl) fluorescein for covalent binding to md-2 and effect on the immune response |
| 06/11/2008 | EP1928495A2 Antibody-mediated enhancement of immune response |
| 06/11/2008 | EP1928465A1 Benzodiazepine derivatives for treating hepatitis c infection |
| 06/11/2008 | EP1928411A2 Use of octenidine dihydrochloride in semisolid preparations |
| 06/11/2008 | EP1750744B1 Medicament for the treatment of fungal infections, particularly aspergillosis |
| 06/11/2008 | EP1620098B1 Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections |
| 06/11/2008 | EP1451184B1 Dimeric compounds and their use as anti-viral agents |
| 06/11/2008 | EP1451182B1 Dimeric compounds and their use as anti-viral agents |
| 06/11/2008 | EP1392334B1 Therapeutic methods using herbal compositions |
| 06/11/2008 | EP1301637B1 Dna vaccines encoding hiv accessory proteins |
| 06/11/2008 | EP1255739B1 3-aminoquinazolin-2,4-dione antibacterial agents |
| 06/11/2008 | EP1230235B1 Compounds with antibacterial and antiparasitic properties |
| 06/11/2008 | CN101198611A Phthalocyanine derivatives, process for their preparation, pharmaceutical compositions containing them, and their use |
| 06/11/2008 | CN101198609A Aspartyl protease inhibitors |
| 06/11/2008 | CN101198374A Antibody or its fragment having anti-HIV neutralizing activity |
| 06/11/2008 | CN101198352A C. perfringens alpha toxoid vaccine |
| 06/11/2008 | CN101198337A Improvement of barrier integrarity in HIV patients by use of fatty acids |
| 06/11/2008 | CN101198320A Herpesvirus-derived therapeutic agent for pain |
| 06/11/2008 | CN101195831A Dual-purpose vaccine carrier for foot and mouth disease virus, production method and application of the same |
| 06/11/2008 | CN101195827A Patina pseudomonas flagellar movement correlation gene PA2950 and application of the same |
| 06/11/2008 | CN101195826A Patina pseudomonas biological tunica forming correlation gene film and application of the same |
| 06/11/2008 | CN101195645A Anti-hepatitis B virus streblus extract and extracting technique thereof |
| 06/11/2008 | CN101195627A New application of benzo [C] phenanthridine and protopine in producing overriding resistant bacterium medicament |
| 06/11/2008 | CN101195620A Entecavir kalium, preparation method and application thereof |
| 06/11/2008 | CN101195609A Method for producing 5,6-dimethyl xanthenone-4-acetic acid, derivant and pharmaceutical formulation produced with the method |
| 06/11/2008 | CN101195604A 4,5-dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity |
| 06/11/2008 | CN101195019A Medicament for treating wet common cold in summer, technique of preparing its preparation and quality control method |
| 06/11/2008 | CN101195008A Cattail pollen skin cleaning agent for treating gynecology disease and technique of preparing the same thereof |
| 06/11/2008 | CN101194997A Chinese medicine preparation for treating AIDS method for preparing the same |
| 06/11/2008 | CN101194995A Proprietary Chinese medicine for treating animal virus, bacterium and mix infection |
| 06/11/2008 | CN101194989A Exterior applied medicament for treating zoster |
| 06/11/2008 | CN101194986A Exterior washing medicament for treating zoster |
| 06/11/2008 | CN101194979A Powder medicament for treating herpes stomatitis |
| 06/11/2008 | CN101194976A Cleaning medicament for treating scald head |
| 06/11/2008 | CN101194973A Infusion medicament for treating impetigo |
| 06/11/2008 | CN101194969A Fumigation medicament for treating dermatophytosis |
| 06/11/2008 | CN101194954A Externally used Chinese medicine for treating tinea versicolor |
| 06/11/2008 | CN101194953A Externally used traditional Chinese medicine composition for treating tinea unguium |
| 06/11/2008 | CN101194944A Technique of preparing medicament for treating upper respiratory tract infection and quality control method |
| 06/11/2008 | CN101194938A Chinese medicine disinfection liquid for tunica mucosa infection |
| 06/11/2008 | CN101194915A Medicament for pig for treating viral high temperature hyperpyrexia |
| 06/11/2008 | CN101194896A Dropping pills containing berberine or berberine salt and method for preparing the same |
| 06/11/2008 | CN101194895A Dropping pills containing ursolic acid and method for preparing the same |
| 06/11/2008 | CN101194705A Gourmet powder with health care function |
| 06/11/2008 | CN100393878C Vaccine |
| 06/11/2008 | CN100393748C Human tumour necrosin antibody, its preparation and medicinal composition |
| 06/11/2008 | CN100393742C Antibacterial tripeptides and modified chemicals, and application |
| 06/11/2008 | CN100393714C Gyrase inhibitors and uses thereof |
| 06/11/2008 | CN100393706C Substituted dihydrochinazolines having antiviral properties |
| 06/11/2008 | CN100393358C Preparation of horse family animal anti human, pultry grippe immune globulin and its medicinal preparation |
| 06/11/2008 | CN100393337C Synergistic medicinal composition |
| 06/11/2008 | CN100393324C Use of Chinese herbal medicine extracts in antivirus activity |
| 06/11/2008 | CN100393314C Combination of Liranaftate gelatin and preparation method |
| 06/11/2008 | CN100393230C Feedstuff addictive and its preparing technology and application in process for manufacturing birds flu-preventing feedstuff |
| 06/10/2008 | US7385059 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators |
| 06/10/2008 | US7385052 Preparing preefrentially linked chemical intermediates; obtain hyaluronic acid, incubate with glutaraldehyde, recover reaction product |
| 06/10/2008 | US7385032 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins |
| 06/10/2008 | US7384976 Nebivolol and its metabolites in combination with nitric oxide donors, compositions and methods of use |
| 06/10/2008 | US7384963 2′-Methyl-5-(1,3,4-oxadiazol-2-yl)1, 1′-biphenyl-4-carboxaide derivatives and their use as p38 kinase |
| 06/10/2008 | US7384960 Cannabinoid CB1 receptor antagonists; e.g. substituted 1,5-dihydroisothiochromeno[4,3-c]pyrazole-3-carboxamide compounds; schizophrenia, memory, appetite disorders |
| 06/10/2008 | US7384957 3,4-dihydro-1H-isoquinolin-2-yl-derivatives |
| 06/10/2008 | US7384950 Respiratory system disorders; asthma; chronic obstructive pulmonary disease |
| 06/10/2008 | US7384948 Graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis; human immunodeficiency viricides |
| 06/10/2008 | US7384928 7-side chain is substituted with aminothiazole and 3-position with a cyclic-type quarternary ammoniummethyl group; antibacterial activities against cephem-resistant Pseudomonas aeruginosa which produce beta -lactamase; antibiotic resistance; pharmacokinetics; high water solubility; injection |
| 06/10/2008 | US7384920 Using a stilbene compound modified with hydroxy or alkoxy groups; antidiabetic agents; viricides |
| 06/10/2008 | US7384911 Also for preventing and treating bacterial and fungal diseases in mammals; agricultural applications; |
| 06/10/2008 | US7384775 Comprises nucleotide sequences coding surface localized streptococcal polypeptides for design of vaccines for prevention of non-systemic diseases such as otitis media; genetic vaccines |
| 06/10/2008 | US7384646 Antiseptic disinfectant, and cosmetics and toiletries, medicine or food containing the same |
| 06/10/2008 | US7384645 Outer membrane vesicles from gram negative bacteria and use as a vaccine |
| 06/10/2008 | US7384643 genetically engineered to be incapable of expressing a native A41L protein; binds to chemokines in the CXC group. |
| 06/10/2008 | US7384636 Which induce an antibody specific to cell surface protein antigen from Streptococcus; use in vaccine production and preventing dental caries |
| 06/10/2008 | CA2418614C Phosphonocephem compound |
| 06/10/2008 | CA2367431C 6-o-substituted macrolides having antibacterial activity |
| 06/10/2008 | CA2365826C Over-coated chewing gum formulations |
| 06/10/2008 | CA2361981C Process for the production of multiple cross-linked hyaluronic acid derivatives |
| 06/10/2008 | CA2358040C Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane |
| 06/10/2008 | CA2341814C Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues |
| 06/10/2008 | CA2319010C Pharmaceutical compositions |
| 06/10/2008 | CA2210799C Valaciclovir hydrochloride in anhydrous crystalline form |
| 06/10/2008 | CA2113562C Poultry mycoplasma antigens, gene thereof and recombinant vectors containing the gene as well as vaccines utilizing the same |
| 06/05/2008 | WO2008066145A1 Thiazole derivative and use thereof as vap-1 inhibitor |
| 06/05/2008 | WO2008066064A1 Regulation of the activity of transcriptional factor stat by zinc ion |
| 06/05/2008 | WO2008065738A1 Bone defect filler, release-controlled carrier, and their production methods |
| 06/05/2008 | WO2008065503A1 (r) -5-methyl-4, 5-dihydro- pyrazole-1, 5-dicarboxylic acid 1- [ ( 4 -chlorophenyl) amide 5-{ [2-fluoro-4- (2-oxo-2h-pyridin-1-yl) -phenyl]amide) as a factor xa inhibitor |
| 06/05/2008 | WO2008065315A1 Immunization protocol against the 4 dengue serotypes |
| 06/05/2008 | WO2008065247A1 Use of beta-lactamase |
| 06/05/2008 | WO2008064488A1 Influenza vaccine formulation |